Hologic Inc (HOLX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Hologic ( HOLX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole was unchanged today. By the end of trading, Hologic fell $0.32 (-1.4%) to $21.70 on light volume. Throughout the day, 2,115,575 shares of Hologic exchanged hands as compared to its average daily volume of 3,343,700 shares. The stock ranged in price between $21.69-$22.05 after having opened the day at $21.93 as compared to the previous trading day's close of $22.02. Other companies within the Health Services industry that declined today were: IsoRay ( ISR), down 16.4%, China Cord Blood ( CO), down 7.7%, Edap TMS ( EDAP), down 7.0% and Hooper Holmes ( HH), down 5.0%.

Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. Hologic has a market cap of $6.2 billion and is part of the health care sector. Shares are up 14.1% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates Hologic as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, Accuray ( ARAY), up 9.0%, Uroplasty ( UPI), up 8.5%, Unilife Corporation ( UNIS), up 7.2% and Synergetics USA ( SURG), up 5.4%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Dow Sinks for Eighth Straight Session; Intel's CEO Departs -- ICYMI

Dow Sinks for Eighth Straight Session; Intel's CEO Departs -- ICYMI

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins